Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study The Data Collection on Adverse Events of Anti-HIV drugs (D:A:D) Study Group

被引:244
|
作者
Worm, S. W. [1 ]
Friis-Moller, N. [1 ]
Sabin, C. A. [1 ]
Sjol, A. [1 ]
Lundgren, J. D. [1 ]
Salbol-Brandt, R. [1 ]
Rickenbach, M. [1 ]
Pezzotti, P. [1 ]
Krum, E. [1 ]
Gras, L. [1 ]
Balestre, E. [1 ]
Sundstroem, A. [1 ]
Delforge, M. [1 ]
Fontas, E. [1 ]
Torres, F. [1 ]
Petoumenos, K. [1 ]
Kjaer, J. [1 ]
Collins, S. [1 ]
Storpher, S. [1 ]
Pearce, G. [1 ]
Rode, R. [1 ]
Weller, I. [1 ]
机构
[1] UCL, Res Dept Infect & Populat Hlth, London NW3 2PF, England
基金
美国国家卫生研究院; 瑞士国家科学基金会;
关键词
death; modifiable risk factors; HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C VIRUS; COMBINATION ANTIRETROVIRAL THERAPY; GENERAL-POPULATION; MORTALITY; OUTCOMES; COHORT; AIDS; INTERRUPTION; INFECTION;
D O I
10.1097/QAD.0b013e32833a0918
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To investigate any emerging trends in causes of death amongst HIV-positive individuals in the current cART era, and to investigate the factors associated with each specific cause of death. Design: An observational multicentre cohort study. Methods: All HIV-positive individuals included in one of the cohorts in the Data Collection on Adverse Events of Anti-HIV drugs (D:A:D) Study were included. The association between HIV-specific and non HIV-specific risk factors and death were studied using multivariable Poisson regression. Results: We observed 2482 deaths in 180 176 person-years (PY) on 33 308 individuals [rate/1000 PY = 13.8 (95% CI 13.2-14.3)]. Primary causes of death were: AIDS (n = 743; rate/1000 PY = 4.12), liver-related (341; 1.89), CVD-related (289; 1.60), non-AIDS malignancy (286; 1.59). The overall rate of death fell from 16.9 in 1999/2000 to 9.6/1000 PY in 2007/2008. Smoking was associated with CVD and non-AIDS cancers, HBV and HCV co-infection with liver-related deaths, and hypertension with liver-related and CVD deaths. Diabetes was a risk factor for all specific causes of death except non-AIDS cancers, and higher current HIV RNA for AIDS-related deaths. Lower CD4 cell counts were associated with a higher risk of death from all specific causes of death. Conclusion: Multiple potentially modifiable traditional and HIV-specific risk factors for death of HIV-infected persons were identified. The maximum reduction in mortality in HIV-infected populations will require that each of these factors be appropriately addressed. No trends in terms of emerging causes of unexpected deaths were observed, although monitoring will continue. (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins
引用
收藏
页码:1537 / 1548
页数:12
相关论文
共 47 条
  • [41] Factors associated with vitamin D deficiency in HIV-1 infected patients on combination antiretroviral therapy: a case-control study
    Calza, Leonardo
    di Pietro, Giulia
    Colangeli, Vincenzo
    Borderi, Marco
    Zaghi, Irene
    Malosso, Pietro
    Bon, Isabella
    Re, Maria Carla
    Viale, Pierluigi
    [J]. NEW MICROBIOLOGICA, 2019, 42 (03): : 145 - 149
  • [42] SYNTHESIS AND ANTIVIRAL STUDY OF CYCLOPENTANO[D]PYRIMIDINE-2,4-DIONES AND OCTAHYDROQUINAZOLINE-2,4-DIONES ACYCLIC NUCLEOSIDES AS POTENTIAL ANTI-HIV AGENTS
    RENAULT, J
    LADUREE, D
    ROBBA, M
    [J]. NUCLEOSIDES & NUCLEOTIDES, 1994, 13 (04): : 891 - 901
  • [43] Novel 2-D phosphorene-based drug delivery system for anti-HIV zidovudine drug to enhance the therapeutic effects: A first-principles based study
    Ullah, Sami
    Akram, Waqas
    Mahmood, Muhammad Saad
    Shazad, Nabeel
    Zahid, Muhammad Nauman
    Iqbal, Javed
    [J]. COMPUTATIONAL AND THEORETICAL CHEMISTRY, 2023, 1229
  • [44] Vitamin-D deficiency impairs CD4+T-cell count recovery rate in HIV-positive adults on highly active antiretroviral therapy: A longitudinal study
    Ezeamama, Amara Esther
    Guwatudde, David
    Wang, Molin
    Bagenda, Danstan
    Kyeyune, Rachel
    Sudfeld, Christopher
    Manabe, Yukari C.
    Fawzi, Wafaie W.
    [J]. CLINICAL NUTRITION, 2016, 35 (05) : 1110 - 1117
  • [45] A phase I study of rGP120W61D with SBAS1 AND SBAS2 compared with alum in HIV negative volunteers:: Adverse events
    McCormack, SMG
    [J]. AIDS, 1998, 12 : S102 - S102
  • [46] Incidence of HIV infection and associated factors among female sex workers in Cote d'Ivoire, results of the ANRS 12361 PrEP-CI study using recent infection assays
    Nouaman, Marcellin N.
    Becquet, Valentine
    Plazy, Melanie
    Coffie, Patrick A.
    Zebago, Clemence
    Montoyo, Alice
    Anoma, Camille
    Eholie, Serge
    Dabis, Francois
    Larmarange, Joseph
    Anrs
    [J]. PLOS ONE, 2022, 17 (11):
  • [47] Review of fasting lipid data from the direct study: Multicenter, open-label, 24-wk pilot with a 24-wk extension to evaluate indinavir (IDV)-ritonavir (RTV) 800/100 BID in combination with D4T & 3TC in HIV-infected individuals. (MERCK 094)
    Schranz, JA
    Wilson, HM
    Jensen, E
    Rawlins, S
    Palmisano, J
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1203 - 1203